Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.

[1]  M. Affrime,et al.  Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses. , 2000, Chest.

[2]  K. Nolop,et al.  Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  S. Peters,et al.  Airway remodeling and persistent airway obstruction in asthma. , 1999, The Journal of allergy and clinical immunology.

[4]  G. Settipane,et al.  Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler. , 1999, Respiratory medicine.

[5]  W. Kreutner,et al.  In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. , 1998, Arzneimittel-Forschung.

[6]  R. Townley,et al.  Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by aeroallergen-specific T-helper type 2 cell lines. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  B. Lipworth,et al.  Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics. , 1997, American journal of respiratory and critical care medicine.

[8]  M. Billah,et al.  The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells. , 1997, The Journal of allergy and clinical immunology.

[9]  P. O'Byrne,et al.  A comparison of the efficacy and safety of inhaled corticosteroids in asthma , 1997, Allergy.

[10]  K. Nolop,et al.  A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. , 1996, The Journal of allergy and clinical immunology.

[11]  William H. Yang,et al.  Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[12]  K. Nolop,et al.  Once‐daily mometasone furoate aqueous nasal spray (Nasonex®) in seasonal allergic rhinitis: an active‐ and placebo‐controlled study , 1996, Allergy.

[13]  N. Hanania,et al.  Adverse effects of inhaled corticosteroids. , 1995, The American journal of medicine.

[14]  S. Pedersen,et al.  Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. , 1994, Respiratory medicine.

[15]  Alfred O. Berg,et al.  Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .

[16]  T. Haahtela,et al.  A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. , 1992, The Journal of allergy and clinical immunology.

[17]  J. Kelly,et al.  SAFETY AND EFFICACY OF MOMETASONE FUROATE CREAM IN THE TREATMENT OF STEROID RESPONSIVE DERMATOSES , 1991, The Australasian journal of dermatology.

[18]  D. Cutler,et al.  62 Lack of systemic activity with intranasal mometasone furoate , 1996 .

[19]  B. Barton,et al.  Cytokine inhibition by a novel steroid, mometasone furoate. , 1991, Immunopharmacology and immunotoxicology.